Editorial: X-linked retinoschisis: mechanisms and therapies
2024
X-linked retinoschisis: mechanisms and therapies
Editorial
Author Information
Author(s): Dumitrescu Alina V., Hartnett Mary Elizabeth, Drack Arlene V.
Primary Institution: The University of Iowa
Conclusion
The original articles in this Research Topic highlight key findings and actionable insights on XLRS progression.
Supporting Evidence
- X-linked retinoschisis is the most common hereditary juvenile macular degeneration in males.
- Gene therapy and other treatments are being explored to improve retinal structure and function.
- Clinical features and disease progression show significant variability among patients.
- Subretinal gene replacement therapy has shown promise in preclinical models.
Takeaway
X-linked retinoschisis is a condition that can cause vision problems, and researchers are exploring different treatments to help improve vision and prevent further damage.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website